Evaluation of the Effectiveness of a Product Containing Topical Hydrocortisone in the Treatment of Seborrheic Dermatitis of the Face
13244/2009
Avaliação da eficácia de um Produto de Uso tópico Contendo Hidrocortisona no Tratamento de Dermatite seborréica na Face.
1 other identifier
observational
60
0 countries
N/A
Brief Summary
Clinical single-blind randomized comparison with the overall objective of evaluating the clinical efficacy of the products Nutracort lotion and Nutracort cream in the treatment of seborrheic dermatitis on the face. Will be held clinical and perceived efficacy assessment and instrumental measurements. Each product will be applied at half face for 7 consecutive days and all applications will be monitored in the research site. 60 volunteers will be recruited. Evaluations will be held at the following times: T0 - before the initial application of the product; T1 - 24 hours after starting treatment, T2 - 48 hours after starting treatment, T3 - 72 hours after initiation of treatment, T4 - 96 hours after the start treatment, T7 - 7 days after initiation of treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2009
CompletedFirst Posted
Study publicly available on registry
December 2, 2009
CompletedStudy Start
First participant enrolled
April 1, 2010
CompletedDecember 2, 2009
December 1, 2009
November 30, 2009
December 1, 2009
Conditions
Eligibility Criteria
Healthy subjects with seborrheic dermatitis on both sides of the face, both sexes, aged 18 to 60 years, skin types I through IV.
You may qualify if:
- Healthy subjects
- Subjects with seborrheic dermatitis on both sides of the face
- both sexes
- aged 18 to 60 years
- skin types I through IV.
You may not qualify if:
- pregnancy / lactation
- skin condition in the area of application of the product
- diabetes
- immune insufficiency
- subjects that are using systemic corticoids
- subjects that are using immunosuppressors
- skin diseases: vitiligo, psoriasis, lupus, atopic dermatitis
- history of reaction to the product category
- other diseases or medications that might interfere directly in the study or endanger the health of the subject
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Allergisa Pesquisa Dermato-Cosmetica LTDAlead
- Galderma R&Dcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 30, 2009
First Posted
December 2, 2009
Study Start
April 1, 2010
Last Updated
December 2, 2009
Record last verified: 2009-12